Kaizen Biotech

Kaizen Biotech is a Singapore-based biotechnology company focused on developing next-generation vaccines and therapeutic solutions for infectious diseases and oncology. The company utilizes its proprietary K-Platform to design and optimize vaccine candidates that aim to provide broader and more durable immune responses compared to traditional methods. Their lead research efforts have focused on pan-sarbecovirus vaccines to address emerging variants of COVID-19 and other respiratory pathogens. Kaizen Biotech collaborates with regional academic and clinical institutions to accelerate the translation of its platform technologies into clinical-stage assets.